Theravance Biopharma, Inc. (NASDAQ:TBPH) Q1 2025 Results Conference Call May 8, 2025 5:00 PM ET Company…
Tag: Biopharma
Xeris Biopharma Holdings, Inc. (XERS) Q1 2025 Earnings Call Transcript
Xeris Biopharma Holdings, Inc. (XERS) Q1 2025 Earnings Call Transcript #Xeris #Biopharma #Holdings #XERS #Earnings #Call…
Quantum BioPharma Corporate Update
Quantum BioPharma Corporate Update#Quantum #BioPharma #Corporate #Update
GC Biopharma Receives MFDS Approval for World's First Recombinant Anthrax Vaccine
GC Biopharma Receives MFDS Approval for World's First Recombinant Anthrax Vaccine#Biopharma #Receives #MFDS #Approval #World039s #Recombinant…
Arbutus Biopharma: A Wing And A Prayer
Arbutus Biopharma: A Wing And A Prayer #Arbutus #Biopharma #Wing #Prayer
Sutro Biopharma stock hits 52-week low at $0.76 amid sharp decline
Sutro Biopharma stock hits 52-week low at $0.76 amid sharp decline#Sutro #Biopharma #stock #hits #52week #sharp…
Xeris Biopharma: Low Risk, Low Excitement Solid Revenue Generator
Xeris Biopharma: Low Risk, Low Excitement Solid Revenue Generator #Xeris #Biopharma #Risk #Excitement #Solid #Revenue #Generator
WuXi XDC Wins Multiple Awards at Asia-Pacific Biopharma Excellence Awards 2025
WuXi XDC Wins Multiple Awards at Asia-Pacific Biopharma Excellence Awards 2025#WuXi #XDC #Wins #Multiple #Awards #AsiaPacific…
Theravance Biopharma: Clinical Progress Is Not Enough To Make It Attractive
Theravance Biopharma: Clinical Progress Is Not Enough To Make It Attractive #Theravance #Biopharma #Clinical #Progress #Attractive
AEON Biopharma executes reverse stock split to comply with NYSE standards
AEON Biopharma executes reverse stock split to comply with NYSE standards#AEON #Biopharma #executes #reverse #stock #split…
Immix Biopharma Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for NXC-201, sterically-optimized CAR-T for relapsed/refractory AL Amyloidosis
Immix Biopharma Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for NXC-201, sterically-optimized CAR-T for relapsed/refractory…
Hansa Biopharma AB (HNSBF) Q4 2024 Earnings Call Transcript
Hansa Biopharma AB (HNSBF) Q4 2024 Earnings Call Transcript #Hansa #Biopharma #HNSBF #Earnings #Call #Transcript
Biopharma industry eyes 2025 bounceback, grapples with uncertainty over Trump return By Reuters
By Deena Beasley SAN FRANCISCO (Reuters) – The biopharmaceutical industry is aiming for a 2025 reversal…
Argent BioPharma Ltd. Raised US$4,500,000 By Investing.com
PERTH, Australia, Jan. 7, 2025 /PRNewswire/ — Argent BioPharma (ASX:RGT) (OTCQB:RGTLF), a clinical-stage biopharmaceutical company addressing…
Sutro Biopharma: I Don’t Buy That Their Pipeline Is Worthless (NASDAQ:STRO)
This article was written by Follow I have my PhD in biochemistry and have worked for…